Lusutrombopag

Indication

For treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure (TA617)

Red

Brand:

Nice TA:

617

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:

Blood and Nutrition

Background

1.1 Lusutrombopag is recommended, within its marketing authorisation, as an option for treating severe thrombocytopenia (that is, a platelet count of below 50,000 platelets per microlitre of blood) in adults with chronic liver disease having planned invasive procedures.

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

Decisions of Lancashire local decision making groups

BwD	BP	CSR	EL	FW	GP	MB	WL
Red	Red	Red	Red	Red	Red	Red	Red

What do the colours mean?

Last Updated: 05 - Mar - 2020